Programme by Day

Print this page

  Personalized Programme
The Personalized Programme enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log on with your username and password to use the Personalized Programme.
» Login
» Create account
» Help
   
« previous day

Saturday, 16 September 2017

 
     
No. S-21 - Symposium
Time: 08.30-10.00
Room: Plenary
Session title: Exercise interventions in schizophrenia - a novel tool for promoting recovery and disentangling underlying pathophysiology
  Peter Falkai, Munich, Germany Chairperson
  Hilleke Hulshoff Pol, Utrecht, Netherlands Co-Chairperson
     
No. S-22 - Symposium
Time: 08.30-10.00
Room: Harvard
Session title: What can we offer long-term inpatients with psychosis: do's and don'ts regarding the treatment and quality of life
  Peter van Harten, Maastricht, Netherlands Chairperson
  Diederik Tenback, Amersfoort, Netherlands Co-Chairperson
     
No. S-23 - Symposium
Time: 08.30-10.00
Room: Stanford
Session title: Reinforcement learning alterations and dopamine dysfunction in psychosis
  Florian Schlagenhauf, Berlin, Germany Chairperson
  Tiago Maia, Lisbon, Portugal Co-Chairperson
     
No. O-05 - Oral Presentation
Time: 08.30-10.00
Room: Princeton
Session title: Neuroimaging
  Kenneth Hugdahl, Bergen, Norway Chairperson
     
No. S-24 - Symposium
Time: 10.30-12.00
Room: Harvard
Session title: Negative symptoms - bridging basic research and clinical application
  Stefan Kaiser, Chęne-Bourg, Switzerland Chairperson
  Tania Lincoln, Hamburg, Germany Co-Chairperson
     
No. S-25 - Symposium
Time: 10.30-12.00
Room: Stanford
Session title: Neurocognitve mechanisms underlying working memory impairments in schizophrenia: new directions
  Robert Bittner, Frankfurt, Germany Chairperson
  Corinna Haenschel, London, United Kingdom Co-Chairperson
     
No. S-26 - Symposium
Time: 10.30-12.00
Room: Princeton
Session title: First episode psychosis: factors that influence burden and outcome
  Ann Faerden, Oslo, Norway Chairperson
  Carmen Simonsen, Oslo, Norway Co-Chairperson
     
No. SA-03 - State-of-the-Art-Lecture
Time: 10.30-12.00
Room: Plenary
Session title: State-of-the-Art Lectures 3
  Peter Falkai, Munich, Germany Chairperson
     
001 Pharmacological therapies for schizophrenia – recent advances and future perspectives  
  W. Wolfgang Fleischhacker, Innsbruck, Austria Speaker
002 Psychological interventions for promoting recovery  
  Anthony Morrison, Manchester, United Kingdom Speaker
  Discussion (15 min)
     
No. PL-03 - Plenary Lecture
Time: 12.15-13.00
Room: Plenary
Session title: Early intervention - the next stage
  Philip McGuire, London, United Kingdom Chairperson
     
001 Early intervention - the next stage  
  Alison Yung, Manchester, United Kingdom Speaker
  Discussion (15 min)
     
No. P-09 - Poster Session
Time: 13.30-14.30
Room: Foyer, Ground Floor
Session title: Psychosocial treatment
  Tania Lincoln, Hamburg, Germany Chairperson
     
001 A meta-analysis of social skills training and related interventions for psychosis  
  David Turner, Edinburgh, United Kingdom Speaker
002 Defeatist performance beliefs in a sample of individuals with persistent negative symptoms  
  Bénédicte Thonon, Ličge, Belgium Speaker
003 Predicting psychotherapeutic sevice use and medication adherence following inpatient care for psychosis  
  Klaus Hesse, Tübingen, Germany Speaker
004 Mentalization based treatment for non-affective psychotic disorder: rationale  
  Jonas Weijers, Utrecht, Netherlands Speaker
005 Robin: a smartphone application approach to support treatment of (attenuated) psychotic symptoms in adolescents  
  Nina Traber-Walker, Zurich, Switzerland Speaker
006 ETRo: evaluation of the combined treatment approach 'Robin' (standardized manual and smartphone App) for adolescents at high risk for developing a psychotic disorder  
  Nina Traber-Walker, Zurich, Switzerland Speaker
007 The effects of a multidisciplinary lifestyle-enhancing treatment for severe mentally ill inpatients (MULTI-study)  
  Jeroen Deenik, Amersfoort, Netherlands Speaker
008 DECIDE study: effectiveness of shared decision making in treatment planning at discharge of inpatient with schizophrenia: 3 years of recruitment, full sample preliminary analysis  
  Jose Villagran, El Puerto de Santa Maria, Spain Speaker
009 Development of a question prompt sheet for schizophrenia: dissemination strategies to raise awareness of Shared Decision Making (SDM) in Japan  
  Yousuke Kumakura, Tokyo, Japan Speaker
010 Impact of self-disclosure of professionals on empowerment of patients: a conversational analysis  
  Alexandra Nguyen, Lausanne, Switzerland Speaker
011 Intensive psychological assistance compared to psychopathological symptoms level among patients diagnosed with paranoid schizophrenia  
  Bogumila Witkowska-Luc, Kielce, Poland Speaker
012 Introducing psychiatric rehabilitation 'Illness Management and Recovery' in Pakistan in collaboration with Rutgers School of Health related professions USA  
  Ajmal Kazmi, Karachi, Pakistan Speaker
     
No. P-10 - Poster Session
Time: 13.30-14.30
Room: Event Area, Ground Floor
Session title: Neuropsychology and neuroimaging 1
  Michelle Servaas, Groningen, Netherlands Chairperson
     
001 The association between cardio-respiratory fitness and cognition in schizophrenia  
  Tom Langerud Holmen, Oslo, Norway Speaker
002 Visual versus auditory cognitive training for schizophrenia: effects on cognition, symptoms and quality of life  
  Rogerio Panizzutti, Rio de Janeiro, Brazil Speaker
003 Working memory training may improve the performance of positive emotion processing in patients with schizophrenia: evidence from an event-related potentials study  
  Shih-Kuang Chiang, Hualien, Taiwan Speaker
004 Auditory mismatch negativity impairments predict response to cognitive training in individuals with early illness schizophrenia  
  Bruno Biagianti, San Francisco, USA Speaker
005 Self-regulation of the dopaminergic reward system via real time fMRI neurofeedback in schizophrenia  
  Matthias Kirschner, Zurich, Switzerland Speaker
006 Dopaminergic and cholinergic influences on prediction error signaling in reward learning: a computational trial-by-trial EEG analysis  
  Sara Tomiello, Zurich, Switzerland Speaker
007 Introducing COMPASS: comparing brain activity across patients with differential treatment response in schizophrenia: an observational study  
  Sandra Iglesias, Zurich, Switzerland Speaker
008 Verbal memory and schizophrenia  
  Markella Fiste, Chaidari Athens, Greece Speaker
009 Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, rarallel, placebo-controlled trial  
  Elena Huerta-Ramos, Sant Boi de Llobregat, Spain Speaker
     
No. P-11 - Poster Session
Time: 13.30-14.30
Room: Event Area, Ground Floor
Session title: Neuropsychology and neuroimaging 2
  Ulrich Schall, Waratah, Australia Chairperson
     
001 Victimization and brain responses to emotional facial expressions in individuals with a psychotic disorder: results of the Beatvic study  
  Elise van der Stouwe, Groningen, Netherlands Speaker
002 Facial emotion recognition and theory of mind in schizophrenia: a meta-analysis of neuroimaging studies  
  Tomas Kasparek, Brno, Czech Republic Speaker
003 Attention bias to threat during the emotional stroop task in paranoid psychosis: an fMRI study  
  Camellia Al-Ibrahim, London, United Kingdom Speaker
004 Changes in limbic activity in fMRI according to response to an emotional paradigm in first-episode psychotic patients with auditory hallucinations  
  Pau Soldevila-Matias, Valencia, Spain Speaker
005 Insight and emotion regulation in schizophrenia: an fMRI study  
  Branislava Curcic-Blake, Groningen, Netherlands Speaker
006 Negative symptoms are associated with altered imagination of positive future events and its neural correlates  
  Nicky Klaasen, Groningen, Netherlands Speaker
007 No relationship between affective state and neurocognition in schizophrenia spectrum disorders  
  Christine Mohn, Drammen, Norway Speaker
008 Disorganized and negative symptoms are associated with neurocognitive impairment in adolescent schizophrenia. Measured with the MATRICS and the Wallwork/Fortgang PANSS Factor Model  
  Runar Elle Smelror, Oslo, Norway Speaker
009 The relationship between theory of mind, empathy and emotion recognition in schizophrenia patients and healthy controls  
  Nora Conradt, Düsseldorf, Germany Speaker
010 The relationship between theory of mind and psychopathological symptoms in schizophrenia  
  Katarzyna Golębiewska, Poznań, Poland Speaker
     
No. P-12 - Poster Session
Time: 13.30-14.30
Room: Event Area, Ground Floor
Session title: Neurobiology and genetics
  Masato Fukuda, Maebashi, Gunma, Japan Chairperson
     
001 Endogenous hormone levels in people with schizophrenia compared with healthy controls  
  Ellen Ji, Créteil Cedex, France Speaker
002 Violation of glutamatergic neurotransmission is found in patients with schizophrenia by the proteomics methods  
  Anastasia Letova, Tomsk, Russia Speaker
003 Evidence for neuroinflammation in post mortem brains of schizophrenic and bipolar patients: a semiquantitative study of B-lymphocytes and plasma cells  
  Johann Steiner, Magdeburg, Germany Speaker
004 Neurohistochemical evidence of T-lymphocyte related neuroinflammation in the cortex and hippocampus of depressed patients  
  Johann Steiner, Magdeburg, Germany Speaker
005 C-reactive protein in schizophrenia-spectrum disorders, relationship to cognitive function in acute phase of psychosis with a longitudinal perspective  
  Farivar Fathian, Bergen, Norway Speaker
006 Establishing pathway profiling as functional diagnostic tool for schizophrenia  
  Sophie-Kathrin Kirchner, Munich, Germany Speaker
007 A systematic appraisal of the MHC gene variation associated with either autism or schizophrenia  
  Barbara Fossi, Florence, Italy Speaker
008 Genetic studies of schizophrenia in South American populations  
  Aida Ruiz, Santiago, Chile Speaker
009 Investigation of the role of schizophrenia de novo mutations in LRRC7 and KHSRP genes by parallel reprogramming of a schizophrenia case-parent trio  
  János Réthelyi, Budapest, Hungary Speaker
010 Chronic stress exposure induced the development of cognitive deficits: involvement of genomic vs non-genomic effect mediated by glucocorticoid receptors  
  Paola Brivio, Milan, Italy Speaker
011 Alteration of the neurotransmission network in the frontal lobe of a genetic mouse model of schizophrenia  
  Shunsuke Morosawa, Nagoya, Japan Speaker
012 Investigation of pupillary light reflex in 'schizophrenia-like' (WISKET) rats  
  Alexandra Büki, Budapest, Hungary Speaker
     
No. S-27 - Symposium
Time: 14.30-16.00
Room: Plenary
Session title: Offspring of parents with psychosis: perinatal indicators of risk and resilience
  Angus MacBeth, Edinburgh, United Kingdom Chairperson
  Susanne Harder, Copenhagen, Denmark Co-Chairperson
     
No. S-28 - Symposium
Time: 14.30-16.00
Room: Harvard
Session title: The role of stressful life events and stress markers in children and adolescents with psychosis or at high risk for psychosis
  Inmaculada Baeza Pertegaz, Barcelona, Spain Chairperson
  Montserrat Dolz Abadia, Esplugues de Llobregat, Spain Co-Chairperson
     
No. S-29 - Symposium
Time: 14.30-16.00
Room: Stanford
Session title: Paranoia - potential vulnerability factors under the spotlight
  Felicity Waite, Oxford, United Kingdom Chairperson
  Katarina Krkovic, Hamburg, Germany Co-Chairperson
     
No. O-06 - Oral Presentation
Time: 14.30-16.00
Room: Princeton
Session title: Neurobiology
  Karl Bechter, Günzburg, Germany Chairperson
     
  Discussion (15 min)